In conclusion, we show that genetic variation in phosphodiesterase 3A leads to altered endothelial function in early life, mostly likely via expression of PDE3A, and also leads to increased risk of ischemic stroke, thus elucidating a pathway by which risk of disease is likely conferred. The gene discussed is PDE3A; the disease is ischemic stroke.